Sonia Molina-Pinelo

15PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 06, 2026
UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.

Ana Gil-Torralvo, M Ángeles Domínguez-Cejudo, Sonia Molina-Pinelo

|Dec 30, 2024
Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression.

Isabel Miras, Ana Gil, Marta Benavent

|Dec 09, 2023
Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.

María A Domínguez-Cejudo, Ana Gil-Torralvo, Mónica Cejuela

|Sep 28, 2023
Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy.

Ángela Marrugal, Irene Ferrer, Álvaro Quintanal-Villalonga

|May 27, 2023
Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.

Mónica Cejuela, Ana Gil-Torralvo, M Ángeles Castilla

|Mar 11, 2023
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer.

Laura Boyero, José Francisco Noguera-Uclés, Alejandro Castillo-Peña

Pageof 3

Frequent Collaborators

4 joint publications

Irene Ferrer

3 joint publications

José Francisco Noguera-Uclés

3 joint publications

Laura Boyero

3 joint publications

Mónica Cejuela